NFATC1 activation by DNA hypomethylation in chronic lymphocytic leukemia correlates with clinical staging and can be inhibited by ibrutinib

Wolf, Christine; Garding, Angela; Filarsky, Katharina; Bahlo, Jasmin; Robrecht, Sandra; Becker, Natalia; Zucknick, Manuela; Rouhi, Arefeh; Weigel, Anja; Claus, Rainer; Weichenhan, Dieter; Eichhorst, Barbara; Fischer, Kirsten; Hallek, Michael; Kuchenbauer, Florian; Plass, Christoph; Döhner, Hartmut; Stilgenbauer, Stephan; Lichter, Peter; Mertens, Daniel

Erstveröffentlichung

2018

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Wolf, Christine

Garding, Angela

Filarsky, Katharina

Bahlo, Jasmin

Robrecht, Sandra

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

International Journal of Cancer ; 142 (2018), 2. - S. 322-333. - ISSN 0020-7136. - eISSN 1097-0215

Link to publication

https://dx.doi.org/10.1002/ijc.31057

Funding information

Bundesministerium fur Bildung und Forschung (BMBF) ({''}PRECiSe{''}) [eBIO-M3-042]
Heidelberg Initiative for Personalized Oncology ({''}HIPO{''}) [h038]
Else Kroner-Fresenius-Stiftung [2012_A146]
Universitat Ulm Sonderforschungsbereich (SFB) [1074]
Jose Carreras Leukamie-Stiftung ({''}DJCLS{''}) [14R/2016, DFG GA 2153/2-1]

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record